Categories : Analgesics & Anti-inflammatory
Product Packaging : 10 / 30 tablets
Product Composition : 50 mg + 325 mg + 30 mg
Send MessageGenliva Wellness LLP manufactures premium quality Aceclofenac + Paracetamol + Nefopam HCL Tablets formulated for effective management of severe pain, inflammation, and musculoskeletal discomfort. This advanced triple-combination medicine is widely used in orthopedic, trauma, and post-operative care for conditions involving acute pain, muscle strain, joint inflammation, and mobility issues. Aceclofenac helps reduce inflammation and swelling, Paracetamol provides analgesic and antipyretic action, while Nefopam HCL acts as a centrally acting pain reliever that enhances pain management effectiveness. The formulation is developed using superior pharmaceutical ingredients to ensure safety, efficacy, and reliable therapeutic outcomes.
As a reliable pharmaceutical manufacturer, pharmaceutical exporter, and contract manufacturing company, Genliva Wellness LLP supplies Aceclofenac + Paracetamol + Nefopam HCL Tablets to domestic and international healthcare markets. Our manufacturing facilities follow stringent quality control standards and advanced pharmaceutical practices to deliver export-quality formulations. With expertise in third-party manufacturing, private label pharmaceutical manufacturing, and global pharma supply solutions, we support distributors, healthcare companies, and pharmaceutical brands with high-quality pain management products.
Aceclofenac + Paracetamol + Nefopam HCL Tablets are formulated to provide comprehensive pain management with enhanced therapeutic effectiveness. The medicine is manufactured under strict pharmaceutical quality systems for consistent performance.
This formulation is widely prescribed for managing acute and chronic pain conditions associated with inflammation and musculoskeletal disorders. It is commonly used in orthopedic and trauma care therapies.
The combination of Aceclofenac, Paracetamol, and Nefopam HCL provides multi-mechanism pain relief for improved therapeutic outcomes and patient comfort.